Research directory
Oncology research
Explore scientific capabilities, research models and practical study resources.
Scientific leadership
Led by Hossein Sendi, M.D., Ph.D.
Our Director of Oncology brings experience in translational cancer research, tumor models, biomarker strategy, therapeutic delivery and preclinical efficacy assessment.
Meet our Director of OncologyBiomarker discovery and molecular profiling MuriPhys coordinates tissue collection, IHC, immunofluorescence and specialist genomic or proteomic workstreams for preclinical biomarker research.Cell line-derived xenograft models Plan CDX research with MuriPhys, from tumor-cell and mouse-model selection through implantation, dosing, tumor monitoring, imaging and tissue analysis.Radiopharmaceutical research MuriPhys radiopharmaceutical research support connects licensed activities, radiolabeled compounds and appropriate biodistribution or oncology endpoints.Genetically engineered mouse models MuriPhys supports genetically engineered tumor-model studies with colony planning, imaging, physiological monitoring and coordinated study execution.Metastatic cancer models Discuss metastatic oncology research with MuriPhys. Plan syngeneic, xenograft or engineered models, implantation, treatment and study-specific imaging.Patient-derived xenograft models Discuss PDX study requirements with MuriPhys, including patient-derived material, model readiness, implantation, dosing and treatment-response endpoints.Syngeneic tumor models MuriPhys supports syngeneic tumor studies in immunocompetent mice. Connect model and strain selection with treatment, tumor monitoring and immune readouts.
A big idea. A tight timeline. Let’s talk.
Bring us your research question. We’ll help you work out the next step.